The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Systemic immune responses induced by intratumoral plasmid IL-12 electroporation in patients with melanoma.
E. Cha
No relevant relationships to disclose
A. Daud
No relevant relationships to disclose
D. G. McNeel
No relevant relationships to disclose
R. Heller
Consultant or Advisory Role - Inovio Pharmaceuticals (U)
Stock Ownership - Inovio Pharmaceuticals
L. Fong
No relevant relationships to disclose